Aby Buchbinder
Impact in
Papers in
- Oncology 30
- Cancer Treatment and Pharmacology 8
- Viral-associated cancers and disorders 7
-
- Cancer therapeutics and mechanisms 8
- Co-authors
- Stuart M. Lichtman (6 shared papers)Jonathan E. Kolitz (4 shared papers)Steven L. Allen (4 shared papers)Philip Schulman (3 shared papers)Nicholas Chiorazzi (3 shared papers)Daniel R. Budman (4 shared papers)Tarun Wasil (3 shared papers)Rajendra N. Damle (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Blood (5 papers)Molecular Cancer Therapeutics (3 papers)Cancer Research (3 papers)American Journal of Hematology (3 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Aby Buchbinder
55 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Genetics 2.1k
- Virology 724
- Pathology and Forensic Medicine 1.6k
- Immunology 1.6k
- Oncology 856
Countries citing papers authored by Aby Buchbinder
This map shows the geographic impact of Aby Buchbinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aby Buchbinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aby Buchbinder more than expected).
Fields of papers citing papers by Aby Buchbinder
This network shows the impact of papers produced by Aby Buchbinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aby Buchbinder. The network helps show where Aby Buchbinder may publish in the future.
Co-authors
The 25 scholars most cited alongside Aby Buchbinder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia Hit paper breakdown → | 1999 | 1897 |
| 2 | 1992 | 280 | |
| 3 | 1993 | 238 | |
| 4 | Distinguishing right from left colon by the pattern of gene expression. | 2003 | 220 |
| 5 | 1997 | 131 | |
| 6 | 1988 | 128 | |
| 7 | 1999 | 117 | |
| 8 | Detection of human B-lymphotropic virus (human herpesvirus 6) sequences in B cell lymphoma tissues of three patients. | 1988 | 110 |
| 9 | 1992 | 76 | |
| 10 | 2013 | 72 | |
| 11 | 1988 | 72 | |
| 12 | 1994 | 65 | |
| 13 | 2009 | 61 | |
| 14 | 1988 | 61 | |
| 15 | 1988 | 55 | |
| 16 | 1988 | 52 | |
| 17 | 2018 | 49 | |
| 18 | 2013 | 45 | |
| 19 | 2013 | 44 | |
| 20 | 1999 | 43 |
About Aby Buchbinder
Aby Buchbinder is a scholar working on Oncology, Molecular Biology, Genetics, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 56 papers that have together received 4.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Cancer Treatment and Pharmacology (8 papers), HIV Research and Treatment (8 papers), Cancer therapeutics and mechanisms (8 papers), Viral-associated cancers and disorders (7 papers), Lymphoma Diagnosis and Treatment (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Genetics (2.1k citations), Virology (724 citations), Pathology and Forensic Medicine (1.6k citations), Immunology (1.6k citations) and Oncology (856 citations). Aby Buchbinder has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Stuart M. Lichtman, Jonathan E. Kolitz, Steven L. Allen, Philip Schulman, Nicholas Chiorazzi, Daniel R. Budman, Tarun Wasil, Rajendra N. Damle, Vincent Vinciguerra and R. Kanti. Their work appears in journals such as Journal of Clinical Oncology, Blood, Molecular Cancer Therapeutics, Cancer Research and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.